ERBB2 and cancer: In addition, because Pertuzumab and trastuzumab work on different domains of the HER2 protein, the combination of Pertuzumab and trastuzumab has a synergistic effect on cancer cells (Lam et al., 2015; Osako et al., 2015; Swain et al., 2015; Williams et al., 2017).